LI
CLBT icon

LRI Investments’s Cellebrite CLBT Stock Holding History

LRI Investments’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
761
+451
+145% +$5.96K ﹤0.01% 933
2026
Q1 		$4.27K Buy
310
+60
+24% +$904 ﹤0.01% 1135
2025
Q4 		$4.51K Hold
250
– – ﹤0.01% 1066
2025
Q3 		$4.63K Hold
250
– – ﹤0.01% 1067
2025
Q2 		$4K Buy
+250
New +$4.46K ﹤0.01% 1069

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return

LRI Investments's CLBT Position: Q2 2026 in Review

LRI Investments increased its Cellebrite (CLBT) stake by 145% in Q2 2026, buying an estimated $5.96K and bringing the position to 761 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #933.

LRI Investments first reported a position in CLBT in Q2 2025 and has held it in 5 quarters since. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • LRI Investments held 761 shares of Cellebrite worth $11.1K as of Q2 2026.
  • LRI Investments bought 451 Cellebrite shares in Q2 2026, an estimated $5.96K.
  • Cellebrite made up ﹤0.01% of LRI Investments's portfolio in Q2 2026, its #933 holding.
  • LRI Investments first reported a position in Cellebrite in Q2 2025 and has held it in 5 quarters since.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.